45
Participants
Start Date
September 3, 2024
Primary Completion Date
October 11, 2027
Study Completion Date
October 11, 2027
Denosumab
Denosumab is a sterile, preservative-free, clear, colorless to pale yellow solution. Each 1 mL single-dose prefilled syringe of denosumab contains 60 mg denosumab (60 mg/mL solution), 4.7% sorbitol, 17 mM acetate, 0.01% polysorbate 20, Water for Injection (USP), and sodium hydroxide to a pH of 5.2.
Placebo
Placebo is 1 mL of normal saline drawn up in a commercially available syringe.
RECRUITING
University of Alabama at Birmingham, Birmingham
RECRUITING
Indiana University, Indianapolis
RECRUITING
City of Hope Medical Center, Duarte
City of Hope Medical Center
OTHER